References
- Wada Y, Nakamura T, Kaneshige M, et al. Evaluation of two glucose meters and interference corrections for screening neonatal hypoglycemia. Pediatr Int. 2015;57(4):603–607.
- Vanavanan S, Santanirand P, Chaichanajarernkul U, et al. Performance of a new interference-resistant glucose meter. Clin Biochem. 2010;43(1–2):186–192.
- Lv H, Zhang GJ, Kang XX, et al. Factors interfering with the accuracy of five blood glucose meters used in Chinese hospitals. J Clin Lab Anal. 2013;27(5):354–366.
- Ceriotti F, Kaczmarek E, Guerra E, et al. Comparative performance assessment of point-of-care testing devices for measuring glucose and ketones at the patient bedside. J Diabetes Sci Technol. 2015;9(2):268–277.
- Gummin DD, Mowry JB, Spyker DA, et al. 2017 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol (Phila). 2018;56(12):1213–1415.
- Budnitz DS, Lovegrove MC, Crosby AE. Emergency department visits for overdoses of acetaminophen-containing products. Am J Prev Med. 2011;40(6):585–592.
- Ho KM, Liang J. Toxic levels of paracetamol falsely elevate blood glucose readings by handheld glucose meter (Glucocard II). Anaesth Intensive Care. 2003;31(3):333–334.
- Klonoff DC, Umpierrez GE, Rice MJ. A milestone in point of care capillary blood glucose monitoring of critically ill hospitalized patients. J Diabetes Sci Technol. 2018;12(6):1095–1100.
- United States Food and Drug Administration. 510(k) Substantial equicalence determination decision summary assay and instrument combination template [published 2016; cited 2019 Nov 8]. https://www.accessdata.fda.gov/cdrh_docs/reviews/K060345.pdf
- Tran NK, Godwin ZR, Steele AN, et al. Clinical impact of accurate point-of-care glucose monitoring for tight glycemic control in severely burned children. Pediatr Crit Care Med. 2016;17(9):e406–412.